Guiding GLP-1 Participants Through The Challenge Of Retention: How MRN's Patient Navigators Support The Physical And Mental Wellbeing Of Participants

Clinical trials for GLP-1 treatments face a distinct retention hurdle; while the therapeutic potential is high, the participant burden is often equally intense. Participants frequently struggle with significant side effects like nausea and fatigue, coupled with the logistical strain of frequent site visits and the emotional toll of lifestyle adjustments. When studies fail to address these human factors, dropout rates spike, and data integrity suffers.

Success in this complex metabolic research landscape requires shifting to a holistic support model that reaches individuals where they live. By integrating remote nutritional coaching, lifestyle guidance, and consistent one-to-one interaction, trial leaders can effectively manage symptoms and stabilize engagement. Access the full case study to explore how specialized support mechanisms are currently driving 95%+ retention rates in complex Phase 2 studies.